Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00345332 · ClinicalTrials.gov registry record · NA
A Multi-Center Trial of Botox for Severe Urge Urinary Incontinence
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT00345332 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 31 participants.
The verdict
NCT00345332, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
The purpose of the study is to determine how effective Botox is in reducing the amount of urine leaked and which dose of Botox is more effective and safe in those who have urinary urge incontinence.
Interventions
- DRUG Placebo
- DRUG Botox
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2005-10 |
| Est. Completion | 2011-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00345332
The ClinicalTrials.gov registry entry for NCT00345332 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00345332 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00345332 about?
NCT00345332 is a clinical study titled "A Multi-Center Trial of Botox for Severe Urge Urinary Incontinence". The purpose of the study is to determine how effective Botox is in reducing the amount of urine leaked and which dose of Botox is more effective and safe in those who have urinary urge incontinence.
What is the current status of trial NCT00345332?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2005-10. Estimated completion is 2011-05.
What interventions are being tested in trial NCT00345332?
The interventions under investigation include: Placebo (DRUG), Botox (DRUG).
Who is sponsoring clinical trial NCT00345332?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.